ATE230027T1 - Menschliche dnase i varianten - Google Patents

Menschliche dnase i varianten

Info

Publication number
ATE230027T1
ATE230027T1 AT95912611T AT95912611T ATE230027T1 AT E230027 T1 ATE230027 T1 AT E230027T1 AT 95912611 T AT95912611 T AT 95912611T AT 95912611 T AT95912611 T AT 95912611T AT E230027 T1 ATE230027 T1 AT E230027T1
Authority
AT
Austria
Prior art keywords
variants
human dnase
actin
relates
resistant
Prior art date
Application number
AT95912611T
Other languages
English (en)
Inventor
Robert A Lazarus
Steven Shak
Jana S Ulmer
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22248728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE230027(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE230027T1 publication Critical patent/ATE230027T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/12Mucolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95912611T 1995-02-24 1995-02-24 Menschliche dnase i varianten ATE230027T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/002366 WO1996026278A1 (en) 1995-02-24 1995-02-24 HUMAN DNase I VARIANTS

Publications (1)

Publication Number Publication Date
ATE230027T1 true ATE230027T1 (de) 2003-01-15

Family

ID=22248728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95912611T ATE230027T1 (de) 1995-02-24 1995-02-24 Menschliche dnase i varianten

Country Status (22)

Country Link
EP (1) EP0811068B1 (de)
JP (1) JPH11505408A (de)
AT (1) ATE230027T1 (de)
AU (1) AU720635B2 (de)
BG (1) BG64061B1 (de)
BR (1) BR9510323A (de)
CA (1) CA2210871C (de)
CZ (1) CZ288633B6 (de)
DE (1) DE69529235T2 (de)
DK (1) DK0811068T3 (de)
ES (1) ES2188653T3 (de)
HU (1) HU223272B1 (de)
MX (1) MX9706428A (de)
NO (1) NO326612B1 (de)
PL (1) PL180773B1 (de)
PT (1) PT811068E (de)
RU (1) RU2215787C2 (de)
SI (1) SI9520153B (de)
SK (1) SK283850B6 (de)
UA (2) UA66749C2 (de)
WO (1) WO1996026278A1 (de)
ZA (1) ZA961419B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK284191B6 (sk) * 1995-02-24 2004-10-05 Genentech, Inc. Aktín-rezistentný variant humánnej DNázy I
US6391607B1 (en) 1996-06-14 2002-05-21 Genentech, Inc. Human DNase I hyperactive variants
EP1433842B1 (de) 2002-12-18 2011-01-05 Roche Diagnostics GmbH Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
DE60335602D1 (de) 2002-12-18 2011-02-17 Roche Diagnostics Gmbh Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
EP2809780B1 (de) 2012-02-01 2018-05-02 Protalix Ltd. Inhalierbare flüssige formulierungen der dnase i

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68929551T2 (de) * 1988-12-23 2008-03-06 Genentech, Inc., South San Francisco Menschliche DNase
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I

Also Published As

Publication number Publication date
CA2210871A1 (en) 1996-08-29
PL180773B1 (pl) 2001-04-30
AU1970395A (en) 1996-09-11
UA65523C2 (en) 2004-04-15
DE69529235T2 (de) 2003-09-04
SK283850B6 (sk) 2004-03-02
SI9520153B (sl) 2004-10-31
ZA961419B (en) 1997-08-22
WO1996026278A1 (en) 1996-08-29
EP0811068A1 (de) 1997-12-10
NO973876L (no) 1997-10-24
HUT77422A (hu) 1998-04-28
SI9520153A (sl) 1998-06-30
DK0811068T3 (da) 2003-03-10
RU2215787C2 (ru) 2003-11-10
NO326612B1 (no) 2009-01-19
BG64061B1 (bg) 2003-11-28
CA2210871C (en) 2009-04-07
DE69529235D1 (de) 2003-01-30
CZ267797A3 (cs) 1998-01-14
SK114797A3 (en) 1998-02-04
BG101846A (en) 1998-07-31
PT811068E (pt) 2003-04-30
AU720635B2 (en) 2000-06-08
JPH11505408A (ja) 1999-05-21
NO973876D0 (no) 1997-08-22
PL321890A1 (en) 1997-12-22
EP0811068B1 (de) 2002-12-18
UA66749C2 (en) 2004-06-15
MX9706428A (es) 1997-11-29
ES2188653T3 (es) 2003-07-01
HU223272B1 (hu) 2004-04-28
BR9510323A (pt) 1997-11-11
CZ288633B6 (cs) 2001-08-15

Similar Documents

Publication Publication Date Title
DK0910647T3 (da) Human DNase i hyperaktive varianter
WO1996034953A3 (en) Cd16-ii variants
ATE330967T1 (de) An her2 bindende peptidverbindungen
EP1071443A4 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
DK1082131T3 (da) Immunoregulator
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
FI972170A (fi) Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, näitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö
DE69529235D1 (de) Menschliche dnase i varianten
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
ATE278011T1 (de) Human dnase ii
MX9706429A (es) Variantes de dnasa i humana.
CA2242562A1 (en) Human dnase resistant to actin inhibition
WO2002050116A3 (en) Adhesion molecule protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0811068

Country of ref document: EP